Home・Listă Acțiuni・Codexis Inc

Codexis Inc

Închisă

SectorSănătate

1.47 -25.38

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

1.46

Maxim

1.55

Indicatori cheie
By Trading Economics
Venit	-18M -8.7M
Vânzări	-24M 15M
EPS	-0.1
Marjă de profit	-57.083
Angajați	146
EBITDA	-23M -6.4M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+395.27% upside

Dividende
By Acuity
Următoarele câștiguri	12 aug. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-27M 201M
Deschiderea anterioară	26.85
Închiderea anterioară	1.47

Sentimentul știrilor

By Acuity

30%

70%

76 / 340 Clasament în Healthcare

Codexis Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 iul. 2026, 19:01 UTC

News

Codexis Inc shares are lower following a public offering of 16.67 million shares at $1.50 each, below Thursday's close of $1.99.

23 iul. 2026, 23:51 UTC

News

Codexis Inc announced a public offering of common stock, contributing to a notable decline in shares during after-market trading.

22 iul. 2026, 20:01 UTC

Codexis Inc shares are lower during Wednesday's session, continuing a trend of declines since Tuesday's close. The stock remains below its 20-day moving average.

Comparație

Modificare preț

Codexis Inc Așteptări

Obiectiv de preț

By TipRanks

395.27% sus

Prognoză pe 12 luni

Medie 7.33 USD 395.27%

Maxim 11 USD

Minim 2 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCodexis Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

4 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 4 analiști care au acordat evaluări ale acțiunilor Codexis Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

76 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.